SCHEMBL6955040

SCHEMBL6955040

CC(C)c1ccccc1Sc1c(O)cc(-c2cc(Cl)cc(Cl)c2)oc1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.36
CNR2 P34972 3/20 0.36
TNKS O95271 1/20 0.36
PARP1 P09874 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
PARP2 Q9UGN5 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.34
CYP1A2 P05177 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
POLB P06746 1/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP2C19 P33261 1/20 0.33
MAOB P27338 3/20 0.33
ABCB1 P08183 1/20 0.33
MEN1 O00255 1/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6963792 0.91 GABRP (0.43) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6954281 0.91 ALDH1A1 (0.42) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6961039 0.88 SMN1; SMN2 (0.46) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6959292 0.87 POLB (0.35) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6965601 0.86 NPSR1 (0.42) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6963494 0.86 PTGES (0.43) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6960294 0.85 QPCT (0.39) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6964073 0.85 AR (0.41) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6960601 0.84 AR (0.41) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL6964481 0.84 TNKS (0.44) TNKSPARP1TNKS2SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed